1. Academic Validation
  2. KSHV miRNAs target STING to evade innate immunity and facilitate KSHV lytic reactivation from latency

KSHV miRNAs target STING to evade innate immunity and facilitate KSHV lytic reactivation from latency

  • Cell Rep. 2025 Jun 24;44(6):115741. doi: 10.1016/j.celrep.2025.115741.
Kimberly Paulsen 1 Rosenna Chan 2 Lauren Gay 3 Zhe Ma 4
Affiliations

Affiliations

  • 1 Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, FL, USA.
  • 2 Department of Microbiology & Cell Science, University of Florida, Gainesville, FL, USA.
  • 3 Department of Molecular Genetics and Microbiology, College of Medicine, University of Florida, Gainesville, FL, USA.
  • 4 Department of Molecular Genetics and Microbiology, College of Medicine, University of Florida, Gainesville, FL, USA; UF Health Cancer Center, Gainesville, FL, USA. Electronic address: zhema@ufl.edu.
Abstract

Kaposi sarcoma-associated herpesvirus (KSHV) employs various strategies to evade host immune surveillance and maintain lifelong latency. The Cyclic GMP-AMP Synthase (cGAS)/stimulator of interferon genes (STING) DNA sensing pathway is a key innate immunity pathway that detects viral DNA and restricts KSHV lytic replication upon reactivation from latency. Here, we identify three KSHV MicroRNAs (miRNAs), miR-K12-6-3p, miR-K12-7-3p, and miR-K12-11-3p, that directly bind to STING1 mRNA to repress its translation and inhibit downstream immune signaling. Exogenous delivery of these KSHV miRNAs led to decreased STING expression and attenuated cGAS/STING signaling in response to STING agonist stimulation. Conversely, genetic deletion of these KSHV miRNAs rescued STING and interferon-stimulated gene expression in latent KSHV cell lines, delaying KSHV lytic reactivation and reducing KSHV lytic gene expression. These findings shed light on the immune evasion strategy of KSHV miRNA-mediated STING repression, representing the discovery of viral miRNAs that target STING.

Keywords

CP: Immunology; KSHV; STING; innate immunity; latency; lytic reactivation; miRNA.

Figures
Products